Synthesis, drug loading and release study of spherical bioactive glass regulated by two templates
Source abstract
Abstract
In this paper, the particle size and morphology of spherical biogalsses(BGs) were regulated by changing the amount of catalyst and templating agent using the dual template method. The prepared BGs had good morphology, dispersibility, and rapid induction of hydroxyapatite generation. The cell activity was above 75 % after co-culture of BG extracts with mBMSCs cells. The surface modification of BG was carried out by γ-aminopropyl triethoxy silane (KH-550) to obtain amino functionalized BG (BG-NH 2), which was then loaded doxorubicin hydrochloride (DOX) to obtain BG-DOX. The maximum loading of BG was 19.2 % and the encapsulation rate was 91.8 %. The drug release rate of BG-DOX was proportional to specific surface area, and it was capable to release DOX at high concentration for up to 10 days, which can be a good drug carrier.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Hydrogels: synthesis, properties, applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Metals as bone repair materials
2. Review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2012.08.023 ↗
3. Bioactive materials for gene control
4. Sr-doped bioactive glasses for biological applications
5. Bioactive glasses and glass-ceramics for healthcare applications in bone regeneration and tissue engineering10.3390/ma11122530 ↗
6. Sol-gel: uncomplicated, routine and affordable synthesis procedure for utilization of composites in drug delivery: review
7. Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive glasses10.1002/jbm.10026 ↗
8. Mesoporous nano-bioactive glass microspheres as a drug delivery system of minocycline
9. Preparation of nano spherical bioglass by alkali-catalyzed mixed template10.1088/2053-1591/abc373 ↗
10. Current advances concerning the most cited metal ions doped bioceramics and silicate-based bioactive glasses for bone tissue engineering10.1016/j.ceramint.2020.09.213 ↗
11. Porous bioactive glass micro- and nanospheres with controlled morphology: developments, properties and emerging biomedical applications10.1039/D0MH01498B ↗
12. Sustainable dual release of antibiotic and growth factor from pH-responsive uniform alginate composite microparticles to enhance wound healing10.1021/acsami.9b04750 ↗
13. Analyte-responsive hydrogels: Intelligent materials for biosensing and drug delivery10.1021/acs.accounts.8b00411 ↗
14. Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity10.1016/j.jcis.2018.02.040 ↗
15. ZnO quantum dots modified bioactive glass nanoparticles with pH-sensitive release of Zn ions, fluorescence, antibacterial and osteogenic properties10.1039/C6TB02053D ↗
16. Gene delivery nanocarriers of bioactive glass with unique potential to load BMP2 plasmid DNA and to internalize into mesenchymal stem cells for osteogenesis and bone regeneration10.1039/C5NR07933K ↗
17. Bio-inspired bioactive glasses for efficient microRNA and drug delivery10.1039/C7TB01021D ↗
18. Preparation and characterization of mesoporous bioactive glass from agricultural waste rice husk for targeted anticancer drug delivery10.1016/j.ceramint.2016.11.007 ↗
19. Monodispersed bioactive glass nanoclusters with ultralarge pores and intrinsic exceptionally high miRNA loading for efficiently enhancing bone regeneration10.1002/adhm.202101616 ↗
20. Mesoporous bioactive glasses for controlled drug release10.1016/j.micromeso.2007.04.041 ↗
21. Well-ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
22. Copper-containing mesoporous bioactive glass nanoparticles as multifunctional agent for bone regeneration10.1016/j.actbio.2017.04.012 ↗
23. Nanoparticle mediated non-covalent drug delivery10.1016/j.addr.2012.05.012 ↗
24. Facile synthesis of bioglass nanospheres for the adsorption of cationic and anionic dyes from aqueous solution10.1080/01932691.2016.1278548 ↗
25. Synthesis of monodispersed mesoporous bioactive glass nanospheres for bone repair10.1016/j.matlet.2016.01.156 ↗
26. Size, shape, charge and “stealthy” surface: carrier properties affect the drug circulation time in vivo
27. Synthesis of chitosan/Al-MCM-41 nanocomposite from natural microcline as a carrier for levofloxacin drug of controlled loading and release properties; Equilibrium, release kinetic, and cytotoxicity10.1016/j.colsurfa.2021.126805 ↗
28. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer10.1016/j.biopha.2017.09.059 ↗
29. Temporally controlled photothermal/photodynamic and combined therapy for overcoming multidrug resistance of cancer by polydopamine nanoclustered micelles10.1021/acsami.9b00472 ↗
30. Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy10.1016/0277-5379(89)90135-1 ↗
31. Doxorubicin-induced cardiotoxicity: causative factors and possible interventions10.1093/jpp/rgac063 ↗
32. Effect of bone marrow-derived mesenchymal stem cells on cochlear function in an experimental rat model10.1002/ar.24065 ↗
33. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
34. Design and evaluation of europium containing mesoporous bioactive glass nanospheres: Doxorubicin release kinetics and Inhibitory effect on osteosarcoma MG 63 cells10.3390/nano8110961 ↗
35. Sol-gel derived terbium-containing mesoporous bioactive glasses nanospheres: In vitro hydroxyapatite formation and drug delivery10.1016/j.colsurfb.2017.09.051 ↗
36. Spherical bioactive glass particles and their interaction with human mesenchymal stem cells in vitro10.1016/j.biomaterials.2010.08.082 ↗
37. Synthesis of silica nanoparticles having a well-ordered mesostructure using a double surfactant system10.1021/ja038250d ↗
38. Hench · 1993
39. Invitro and invivo examination for bioceramic degradation
40. Research on the biological activity and doxorubicin release behavior in vitro of mesoporous bioactive SiO2-CaO-P2O5 glass nanospheres10.1016/j.apsusc.2017.05.078 ↗
41. Wang · 2009